ABSTRACT Platelet basic protein (PBP) (isoelectric point, 10.0-10.5; apparent Mr, 11,000-15,000) has been purified to homogeneity from material secreted by fresh human platelets after stimulation by thrombin. The purification, usingpreparative isoelectric focusing and chromatography on heparinSepharose, yielded two additional peptides with antiheparin activity that were immunologically identical with PBP: lowaffinity platelet factor 4 and Inthromboglobulin. The purity of the peptides was confirmed by immunoelectrophoresis and by WNH14te6minal amino acid analysis. Dansyl chloride-treated PBP yief*d a single dansylated amino acid residue (glycine). By iusinisjpecific radioimmunoassay it was shown that 109 human platelets contain 2-3 p&g of PBP which can be released in response to specific stimulation. PBP is associated with mitogenic activity as assayed in Swiss 3T3 mouse cells cultured in lowserum (0.4-1.5%) medium at levels of about 1 ng/ml and saturating at 10-40 ng/ml. The biological activity of different PBP preparations was variable, presumably due to inhibition by the varying amounts of ampholytes that interfered with the mitogenic activity of the peptide. Mitogenic activity was eluted from NaDodSO4/polyacrylamide gels and shown to comigrate with immunoreactive material and with conventional marker proteins of 14,000-17,000 daltons or with histones of 11,000-15,000 daltons. Evidence is presented that PBP is different from cationic platelet-derived growth factor which has an apparent M, of 30,000. Most mammalian cells require serum for growth in culture. The most prominent serum mitogens appear to be peptides derived from platelets. Several preparations of platelet growth factors of varying degrees of purity have been described (1-4). These factors are clearly different from fibroblast growth factor (5) and epidermal growth factor (EGF) (6). Recently, two papers reported the purification of "platelet derived growth factor" from outdated human platelets (7, 8) . However, these preparations have not been sufficiently characterized although there is suggestive evidence that the two peptides are identical.
yief*d a single dansylated amino acid residue (glycine). By iusinisjpecific radioimmunoassay it was shown that 109 human platelets contain 2-3 p&g of PBP which can be released in response to specific stimulation. PBP is associated with mitogenic activity as assayed in Swiss 3T3 mouse cells cultured in lowserum (0.4-1.5%) medium at levels of about 1 ng/ml and saturating at 10-40 ng/ml. The biological activity of different PBP preparations was variable, presumably due to inhibition by the varying amounts of ampholytes that interfered with the mitogenic activity of the peptide. Mitogenic activity was eluted from NaDodSO4/polyacrylamide gels and shown to comigrate with immunoreactive material and with conventional marker proteins of 14,000-17,000 daltons or with histones of 11,000-15,000 daltons. Evidence is presented that PBP is different from cationic platelet-derived growth factor which has an apparent M, of 30,000. Most mammalian cells require serum for growth in culture. The most prominent serum mitogens appear to be peptides derived from platelets. Several preparations of platelet growth factors of varying degrees of purity have been described (1) (2) (3) (4) . These factors are clearly different from fibroblast growth factor (5) and epidermal growth factor (EGF) (6) . Recently, two papers reported the purification of "platelet derived growth factor" from outdated human platelets (7, 8) . However, these preparations have not been sufficiently characterized although there is suggestive evidence that the two peptides are identical.
Thrombin and other platelet-aggregating agents induce platelets to secrete proteins and peptides (9) which bind to heparin with either high affinity, such as platelet factor 4 (10), or with low affinity, such as low-affinity platelet factor 4 (LA-PF4) (11, 12) and f(-thromboglobulin (j3-TG) (13) . The biological roles of these peptides are largely unknown. Here we report the purification of a new platelet-secreted peptide associated with antiheparin and mitogenic activities. We propose to call it platelet basic protein (PBP). PBP appears tQ be immunologically identical with LA-PF4 and ,B-TG. 21 Ci/mmol; 10,Ci per dish, 6 ,uM; 1 Ci = 3.7 X 1010 becquefels) was added 16 hr later. This mixture was incubated for 8 hr. Trichloroacetic acid-precipitable radioactivity retained on glass fiber filters was determined in a liquid scintillation counter. Formalin-fixed cultures were prepared for autoradiography using Kodak AR1O stripping film. EGF prepared by the method of Savage and Cohen (6) was kindly provided by R. Savage (Temple University Medical School).
MATERIALS AND METHODS
Platelet-Secreted Antiheparin Proteins. These were prepared by using platelets from freshly drawn human blood. Washed platelets (14) were incubated (15 min, 37°C) with pure thrombin (3000 units/mg of protein) kindly provided by J. W. Fenton (New York State Department of Health, Albany, NY) to induce aggregation and secretion. The cells were removed by centrifugation. The supernatant containing platelet-secreted proteins was heated (100°C, 10 min), dialyzed against 1% glycine (pH 9.0), and fractionated on an LKB isoelectric focusing column in 1.5% ampholytes, pH 3.5-10 (Pharmacia), in a sucrose gradient. Fractions were dialyzed against 1.0 M NaCl for 3 days (three changes) and then against 0.15 M NaCl for 3 days; after this they were lyophilized. The material was adsorbed on heparin-Sepharose, which was prepared by coupling heparin (Sigma) to CNBr-activated Sepharose (Pharmacia). The column was washed with 0.05 M NaCl/0.01 M Tris, pH 8.0, and antiheparin proteins were eluted with 0.5 M NaCl. Fractions were dialyzed against 1.0 M NaCl and then These preparations were used for mitogenic assays. The yield of mitogenic PBP was usually 5-10% of that in the procedure used for the preparation of PBP for biochemical and immunological characterization.
Antigens. The following antigens were used for immunizations of rabbits. (a) Low affinity-antiheparin peptides (LA-AHP) were obtained as described (11) from the supernatant after aggregation of washed platelets by thrombin, followed by heating, ZnSO4 precipitation, and affinity chromatography on heparin-Sepharose. As currently determined by a combination of isoelectric focusing and radioimmunoassay, this preparation contains 76% LA-PF4, 20% f3-TG, and 3% PBP.
This prepatation was referred to previously as "low-affinity platelet factor 4" (11) . For simplicity, we will refer to this Antibodies. Antiserum against LA-AHP was raised in rabbits'
injected with the antigen emulsified with complete Freund's adjuvant. Antisera against LA-PF4, f3-TG, and PBP were produced in 3-month-old New Zealand rabbits after a single multiple-site immunization (15) . Antibody against LA-PF4 was purified by affinity chromatography of anti-LA-AHP gamma globulin on LA-PF4 coupled to w-aminobutyl-Sepharose (Pharmacia) by the carbodiimide method. Analytical Methods. Radioimmunoassay of secreted platelet proteins was as described (11 For NaDodSO4/polyacrylamide slab gel electrophoresis, gels were prepared according to Laemmli (17) . Polyacrylamide gels (10%) containing 0.27% tetramethylenediamine and 0.1% NaDodSO4 were run at iz100 V and 20 mA for 2-3 hr and stained with 0.5% Coomassie brilliant blue. Calf thymus histones (Sigma) or conventional standards (Bio-Rad) were run as molecular weight markers. For the elution of peptides, gels were cut into 1-cm pieces, crushed, and incubated with 1 M NaHCO3 (24 hr, 4°C). For removal of NaDodSO4, eluted material was passed over a Dowex 1 X 2-100 (1 mM Tris buffer, pH 7.0) and Iyophilized.
NH2-Terminal amino acid analysis was by a modification of the procedure described by Gray (18) . Immunoelectrophoresis (19) and immunodiffusion (20) (11-13) ; Dansylated preparations of LA-PF4 yielded two amino acid derivatives: a major spot corresponding to aspartic acid and a minor one corresponding to glycine. This observation has been confirmed (12) by quantitative Edman degradation which showed that LA-PF4 prepared as described here contained 86% NH2-terminal asparagine and 14% NH2-terminal glycine. On NaDodSO4/polyacrylamide gel electrophoresis, LA-PF4, and 3-TG showed single bands. PBP preparations showed two major bands: one band corresponding to protein and the second corresponding to ampholytes (Fig. 2) . The PBP corresponded Mr 15000-16,000 or 11,000-13,000 when compared to conventional markers or to histones, respectively. Histones are more Material released in response to thrombin was heated (100'C, 10 min) and fractionated at 4VC by using an LKB isoelectric focusing column (110 ml) containing 1.5% ampholytes, pH 3.5-10, in a sucrose density gradient. After 25 hr, fractions (1.2 ml) were collected and LA-AHP levels were determined by radioimmunoassay. The amounts of LA-PF4 (pl, 8.0), fl-TG (pl, 6.9), and PBP (pl, 10.9) were 600, 120, and 95 jig, respectively. The recovery was 67%.
Cell Lower slide: LA-PF4 above; PBP below. The volume of antigen applied was 6 $l (600 ,ug/ml); the volume of gamma globulin in the trough was 50 $l.
resulting in identical competition curves (Fig. 4) . Furthermore, LA-PF4, f,-TG, and PBP were precipitated equally well by antiserum to either pure PBP or pure LA-PF4. Also, radioimmunoassay competition curves with 125I-labeled LA-PF4 and unlabeled LA-PF4 or PBP were identical with either anti-LA-PF4 or anti-PBP antiserum (data not shown). It had been shown previously (11, 12) that ,B-TG is immunologically identical to LA-PF4. It is concluded that LA-PF4, ,B-TG, and PBP share common and equivalent antigenic determinants. Therefore, the radioimmunoassay originally developed (using anti-LA-AHP antiserum) is suitable for quantitative determination of the three peptides described here and for monitoring purity of PBP during the purification (Table 1) . Mitogenic Activity. The pure PBP preparation stimulated DNA synthesis in 3T3 cells cultured in 1.5% serum ( Table 2) . With one of the most active preparations of PBP, activity was observed at 1 ng/ml and was saturated at 10-40 ng/ml. It was somewhat less active than EGF. For reasons which are not understood, only ;70% or 50-55% of the cells responded to stimulation by EGF or PBP, respectively, under optimal conditions, whereas the responses to fibroblast growth factor at 10 ng/ml (5) (not shown) or to 4% serum (Table 2) were significantly higher (-90%). Addition of PBP at 100 ng/ml to quiescent cells in 5% human plasma caused an increase of cell number from 3 X 104 on day 0 to 14 X 104 (+10%) on day 5 . In the absence of PBP, the number of cells increased to 5.1 x i04. The mitogenic activity was destroyed by pepsin (at pH 2), confirming that PBP is a protein. The mitogenic activity of PBP varied considerably from one preparation to another, possibly depending on the extent of contamination by ampholytes (which inhibited the response of cells to mitogenic stimuli) or on the extent of degradation of the peptide during storage.
To confirm the molecular weight of the mitogenic material directly, the activity associated with PBP was recovered from NaDodSO4/polyacrylamide gels with a yield of about 15-25% as determined by radioimmunoassay (Fig. 5) . The peak of mitogenic activity (fraction 8) coincided with the peak of immunoreactive material on radioimmunoassay and corresponded to the position of PBP within a Mr range of 14,000-17,000 (conventional marker proteins) or 11,000-15,000 (histone markers). No mitogenic activity was eluted from gels at the position corresponding to Mr 25,000-35,000.
It was difficult to evaluate the specific mitogenic activity of PBP during the process of purification for the following reasons: (i) serum was more active than saturating levels of PBP (or EGF) in the assay system used here; (i) ampholytes interfered with the mitogenic assay and were responsible for the variability of the results; and (iii) protein levels could not be determined reliably in these preparations due to the presence of ampholytes. DISCUSSION Preparations of PBP isolated from material secreted by fresh human platelets appeared to be homogeneous as shown by NH2-terminal amino acid determinations, immunodiffusion, isoelectric focusing, and immunoelectrophoresis. Immunoreactive PBP has been purified about 83,000-fold compared to platelet-rich plasma (Table 1 ; Fig. 1 (1980) from outdated platelets (1, 3, 4, 7, 8, 24 ). PBP and other cationic platelet growth factors are characterized-by considerable heat stability, sensitivity to proteolytic enzymes, and low molecular weight. Recently, two papers described the purification, from extracts of outdated platelets, of platelet-derived growth factors mitogenic for 3T3 (7) or human glial cells (8) . Although the three highly purified cationic mitogenic peptides are similar to some extent, there appear to be considerable differences among them. NaDodSO4/polyacrylamide gel electrophoresis (nonreducing conditions) leads to an estimate of 30,000 for the Mr of platelet-derived growth factors (7, 8) . The apparent Mr of the main constituent of purified PBP preparations is 11,000-15,000 daltons as judged by gel electrophoresis with histones as markers and 14,000-17,000 with standard markers. Preliminary studies have shown that the displacement of '25I-labeled LA-PF4 from homologous antibody by an excess of platelet-derived growth factors (kindly provided by C. H. Heldin and A. Wasteson, Uppsala, Sweden) is <5%. This suggests that antigenic determinants of platelet-derived growth factors are different from those in LA-PF4 or PBP.
It appears that PBP is different from the cationic 30,000-dalton platelet-derived growth factor purified by Antoniades et al. (7) and by Heldin et al. (8) . The possibility that the mitogenic activity associated with PBP preparations might be due to contamination by platelet-derived growth factor is unlikely as shown by experiments in which mitogenic activity was eluted from NaDodSO4/polyacrylamide gels (Fig. 5) . The bulk of mitogenic activity was eluted from gel slices corresponding to Mr 11,000-15,000; no activity was eluted from the region corresponding to the apparent Mr of platelet-derived growth factors as reported by other investigators (7, 8) . The existence of two distinct platelet growth factors [PBP and that of Antoniades et al. (7) and Heldin et al. (8) ] is further strengthened by the observation that their mitogenic activities were of similar orders of magnitude when assayed in our laboratory (data not shown).
